ATELVIA Drug Profile, 2020

$600.00

ATELVIA Drug Profile, 2020

This report focuses on ATELVIA and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • Annual sales revenues
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources
SKU: 022560 Category:

Description

ATELVIA Drug Profile, 2020

This report focuses on ATELVIA and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • Annual sales revenues
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources

Contents

  • Profile for ATELVIA
  • US Patents
  • Expired US Patents
  • Paragraph IV Patent Challenges
  • US District Court Litigation
  • International (exUS) Patents
  • Annual Sales Revenues
  • Finished Product Suppliers
  • Bulk API Sources